SMTL ID : 5cn0.1

Artificial HIV fusion inhibitor AP2 fused to the C-terminus of gp41 NHR

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.90 Å

Oligo State

homo-trimer

Ligands

3 x MG: MAGNESIUM ION(Non-covalent)

MG.1: 1 residues within 4Å: Chain A: S.38 No protein-ligand interaction detected (PLIP) MG.4: 1 residues within 4Å: Chain B: S.38 No protein-ligand interaction detected (PLIP) MG.7: 1 residues within 4Å: Chain C: S.38 No protein-ligand interaction detected (PLIP)

6 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)

PEG.2: 3 residues within 4Å: Chain A: L.24, W.27 Chain B: K.50 1 PLIP interactions: 1 interactions with chain B Hydrogen bonds: B:K.50 PEG.3: 5 residues within 4Å: Chain A: Q.23, V.26, W.27, K.30, I.55 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:Q.23, A:K.30 Water bridges: A:K.30 PEG.5: 3 residues within 4Å: Chain B: L.24, W.27 Chain C: K.50 1 PLIP interactions: 1 interactions with chain C Hydrogen bonds: C:K.50 PEG.6: 5 residues within 4Å: Chain B: Q.23, V.26, W.27, K.30, I.55 3 PLIP interactions: 3 interactions with chain B Hydrogen bonds: B:Q.23, B:K.30 Water bridges: B:K.30 PEG.8: 3 residues within 4Å: Chain A: K.50 Chain C: L.24, W.27 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:K.50 PEG.9: 5 residues within 4Å: Chain C: Q.23, V.26, W.27, K.30, I.55 3 PLIP interactions: 3 interactions with chain C Hydrogen bonds: C:Q.23, C:K.30 Water bridges: C:K.30

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zhu, X. et al., Improved Pharmacological and Structural Properties of HIV Fusion Inhibitor AP3 over Enfuvirtide: Highlighting Advantages of Artificial Peptide Strategy. Sci Rep (2015)

Release Date

2015-09-16

Peptides

Envelope glycoprotein,AP2: ABC

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
A

C
A

Envelope glycoprotein,AP2